Description
In 2019, the Department of Justice continued its focus on enforcing its criminal laws against individuals. In particular, the DOJ’s FCPA unit brought charges against an unprecedented number of individuals. This trend of individual enforcement in FCPA cases and more generally is expected to continue.
Since issuance of the Yates Memo in 2015, the DOJ has maintained its focus on targeting individuals for corporate misconduct. The DOJ updated its U.S. Attorneys’ Manual in late 2018 and incorporated the Yates Memo, which outlines six fundamental principles--five of which specifically address the prosecution of individuals. The government apparently believes, correctly in our view, that taking meaningful enforcement action against individuals is an effective means of deterring misconduct.
In this timely program, our panelists will examine the impact of the DOJ’s focus on individual enforcement, both to date and on a going forward basis. Among other things, the panel will review the following:
- What types of conduct is the DOJ pursuing in individual enforcement actions under the FCPA?
- In what other areas of law is DOJ focusing its efforts?
- How are companies responding to more aggressive individual enforcement?
- What are the tangible effects on companies’ compliance efforts since the Yates memo?
- How should companies and senior executives, as well as directors, protect themselves from individual liability?
Presented By
Mr. McBride represents companies and individuals in international trade regulatory, compliance, investigative, and enforcement matters involving U.S. economic sanctions and economic embargoes, U.S. export controls, FCPA, U.S. anti-boycott controls, U.S. customs and other import controls, anti-money laundering and other banking controls, and U.S. international trade enforcement and regulatory actions.
Ms. Yi represents companies in connection with internal and government investigations concerning white collar and corporate compliance matters. In addition, she regularly works with healthcare companies on healthcare fraud and abuse issues related to alleged violations under the False Claims Act, Anti-Kickback Statute and Stark Law. Prior to joining the firm, she worked as an Investigator in the Office of Fraud Detection and Market Intelligence at the Financial Industry Regulatory Authority (FINRA). She conducted investigations of potential federal securities laws and FINRA rule violations.
-
This 90-minute webinar is eligible in most states for 1.5 CLE credits.
-
Date + Time
- event
Tuesday, April 7, 2020
- schedule
1:00 p.m. ET./10:00 a.m. PT
- Background
- Relevant standards governing enforcement against individuals
- Examples of recent enforcement actions
- Practical implications for companies and their counsel
- Best practices for compliance: what companies should do now
The panel will review these and other key issues:
- How is DOJ policy regarding individual accountability being reflected in DOJ enforcement actions?
- What are the implications of the DOJ policy shift for companies?
- How are companies and counsel changing their approach to internal investigations and cooperation in light of the Yates Memo?
